RHOA and neoplasm: We further show that although pharmacological inhibition of ATX activity per os is not efficient to prevent tumour growth because of a positive feedback regulation that induces the expression of ATX in tumour cells, the combined opposite targeting of p110δ and RhoA bypasses this positive feedback expression of ATX.